Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Operating Activities
Net Income $-314.0M $37.0M $245.0M $2.51B $-141.0M $44.0M $181.0M $-2.94B
Depreciation & Amortization $227.0M $271.0M $264.0M $92.0M $315.0M $313.0M $18.0M $331.0M
Depreciation $73.0M $113.0M — — — — — —
Amortization $154.0M $158.0M $124.0M $147.0M $157.0M $162.0M $101.0M $168.0M
Stock-Based Compensation $20.0M $17.0M $25.0M $28.0M $37.0M $25.0M $18.0M $45.0M
Net Cash from Operating Activities $115.0M $163.0M $531.0M $365.0M $351.0M $479.0M $439.0M $290.0M
Investing Activities
Capital Expenditures — — $-70.0M $174.0M $156.0M $172.0M $-61.0M $161.0M
Business Acquisitions — — $-2.0M $3.0M $0 $3.0M $52.0M $16.0M
Net Cash from Investing Activities $-91.0M $-166.0M $-230.0M $3.79B $-173.0M $-170.0M $-256.0M $-184.0M
Financing Activities
Dividends Paid $148.0M $147.0M $147.0M $147.0M $146.0M $146.0M $146.0M $146.0M
Stock Repurchases — — — — — — $0 $32.0M
Net Cash from Financing Activities $-936.0M $-140.0M $-2.94B $-62.0M $-120.0M $-372.0M $-119.0M $-302.0M
Net Change in Cash $-934.0M $-168.0M $-2.59B $4.07B $49.0M $-45.0M $118.0M $-252.0M
Free Cash Flow — — $601.0M $191.0M $195.0M $307.0M $500.0M $129.0M
← Newer Page 2 of 9 Older →